Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Personalized Breast Cancer Screening: Moving Beyond Age-Based Algorithms
Breast cancer screening has traditionally been organized around two principal variables: when mammography should begin and how frequently it should be performed.
The article examines the objective, findings, and clinical context described in Personalized Breast Cancer Screening: Moving Beyond Age-Based Algorithms.
Approach:
Screening guidance: The article contrasts USPSTF biennial mammography for average-risk women ages 40–74 with the American College of Radiology’s recommendation for annual mammography from age 40 and risk assessment by age 25.
Risk assessment: It discusses breast density alongside family history, inherited susceptibility, and prior breast findings as factors in individualized assessment.
Care after an abnormal result: It describes diagnostic follow-up, staging, and multidisciplinary treatment planning, including individualized radiation and systemic therapy.
Key Findings:
Dense breast tissue is associated with increased cancer risk and can reduce mammographic sensitivity.
The USPSTF finds insufficient evidence to recommend for or against supplemental MRI or ultrasound solely for dense breasts after a negative mammogram; supplemental MRI may increase detection as well as recalls and biopsies.
The American Cancer Society recommends annual MRI in addition to mammography for certain high-risk women, generally beginning around age 30.
Treatment decisions may reflect stage, lymph-node status, tumor biology, surgery, and patient-specific factors; selected patients may receive less intensive therapy while maintaining outcomes and reducing toxicity, according to an oncologist quoted in the arti…
The USPSTF emphasizes follow-up testing and biopsy when indicated after abnormal mammograms and notes disparities in stage at diagnosis and mortality, particularly among Black women.
Interpretation:
The article presents age-based screening as a starting point and describes risk assessment and timely follow-up as relevant to screening and subsequent care.
Limitations:
The provided article context ends mid-sentence, so its discussion of coordinated breast-program services is incomplete.
The context does not provide study methods or detailed evidence supporting the quoted treatment claims.